Fernando Albericio is Research Professor at the University of KwaZulu-Natal in Durban, South Africa and Full Professor of Organic Chemistry at the University of Barcelona. He was Founder and General Director of the Barcelona Science Park and Inaugural Rector of Yachay Tech. His major research interests cover practically all aspects of peptide synthesis (new reactions, building blocks, solid phase supports, protecting groups, and linkers) and combinatorial chemistry methodologies, as well as synthesis of peptides and small molecules with therapeutic activities. Furthermore, his group is also involved in developing new systems for drug delivery and strategies for diagnostics as well.
Dr. Dianping Tang, Full Professor for Analytical Chemistry at the Fuzhou University, China, was born in 1972. Dr. Tang received his diploma degree in biochemistry from Sichuan Three Gorges University of China in 1986, and his Ph.D. degree from the Southwest University of China. His research interests mainly include Clinical/Environmental immunoassays, Biological and Chemical microsensors, Synthesis and application of advanced functional nanomaterials, and Fabrication of microfluidic device. At present, his projects are focused on two areas: (i) Synthesis of advanced functional nanomaterials and application in biological and chemical microsensors, and (ii) design and fabrication of a new family of immunoassays based on micro- and nano-fluidic devices.
Gerrit Borchard is a licensed pharmacist and obtained his PharmD and Ph.D. in pharmaceutical technology from the University of Frankfurt (Germany). Dr. Borchard is Full Professor in Biopharmaceutical Sciences at the University of Geneva (Switzerland), has published more than 135 scientific paper and book chapters (6769 citations, h-factor 43), and is named as inventor on 7 patents. Since 2014, he serves as President of the Swiss Academy of Pharmaceutical Sciences (SAPhS).
CALICETI PAOLO, master degree in Pharmaceutical Chemistry and Technology and PhD in Pharmaceutical Sciences at the University of Padova, is Full Professor in Pharmaceutical Technology and Head of Department of Pharmaceuitcal and Pharmacological Sciences of University of Padua. Invited scientist at NIH (USA, 1986/1987), Academy of Sciences of Moscow (1990), SmithKline Beecham Pharmaceuticals, (USA, 1994). Main topics of work: protein PEGylation; nano-/micro-particles by supercritical techniques; stimuli sensitive and targeted polymer bioconjugates, gold nanoaprticles, micelles, lipoosmes and polymersomes for drug delivery. Member of editorial boards and international committees for project funding; President of CRS Italy Chapter. Patents 17, Publications over 160; Invited presentations over 80.
Liviu Movileanu has studied physics (1985-1990) and received the Ph.D. degree in biophysics from the University of Bucharest (1997). He has acquired postdoctoral positions at the University of Missouri (Kansas City, USA, 1997-1998) and the Texas A&M University Health Science Center (College Station, Tex, USA, 1999-2004). Currently, he is a Professor of Physics at Syracuse University (Syracuse, New York, NY, USA). He has published about 65 papers in international scientific journals and has delivered more than 140 invited talks worldwide. He is also affiliated to Syracuse Biomaterials Institute (SBI), SUNY Upstate Cancer Research Institute, and Institute of Complex Adaptive Matter (ICAM-I2CAM). He has been awarded an Associate Member Fellowship of the Abdus Salam International Center for Theoretical Physics (1997) and a Research Fellowship of the TEMPUS Program of the European Community (1997). Currently, his research group is funded by the US National Institutes of Health. His expertise areas include single-molecule and membrane biophysics, chemical and synthetic biology, bionanotechnology and nanomedicine, biosensors and functional biomaterials, biological statistics, and numerical analysis of stochastic biological processes.
Luke P. Lee is the Arnold and Barbara Silverman Distinguished Professor of Bioengineering at University of California, Berkeley, Co-Director of Berkeley Sensor & Actuator Center, and Director of the Biomedical Institute of Global Healthcare Research & Technology (BIGHEART). Professor Lee’s current research interests are bionanoscience, nanomedicine for global healthcare and personalized medicine, Bioinspired Photonics-Optofluidics-Electronics Technology and Science (BioPOETS) for green building with living skin. Professor Lee received his B.A. degree in Biophysics and his Ph.D. degree in Applied Science & Technology: Applied Physics (major) / Bioengineering (minor) from the University of California, Berkeley.
Dr. Paolo Decuzzi obtained a doctorate (Ph.D.) in Mechanical Engineering from the University of Naples – Federico II in Italy. Dr. Decuzzi has over 15-year research experience in nanoengineering, microfluidics and nanomedicine, as documented by over 150 published papers. Dr. Decuzzi has been a visiting scholar and professor at the University of Michigan; Princeton Materials Institute; Ohio State University; and a professor of Biomedical Engineering at the University of Texas and Methodist Hospital in Houston. Currently, he is a senior scientists at the Italian Institute of Technology where he is the founder and director of the Nanotechnology for Precision Medicine – nPMed – Lab.
Dr. Christy Hunter is a Senior Lecturer in Pharmaceutical Nanoscience at the Manchester School of Pharmacy, University of Manchester, UK. He received his first degree in pharmacy from the University of Brighton and following pre-registration training in hospital qualified as a pharmacist in 1993. He still locums in community pharmacy. His post graduate studies were in bioorganic chemistry (1993-1996) at the University of Sussex. Following a shortened post-doctoral fellowship in polymer synthesis he was appointed to faculty in the School of Pharmacy at the University of Brighton, lecturing in Advanced Drug Delivery and Particulate Nanomedicine within the division of Pharmaceutics (1998-2012).
Dan Peer is a Professor and the Director of the Laboratory of Precision NanoMedicine at Tel Aviv University (TAU). He is the Director of a national nanomedicine initiative project. He is also the Director of Leona M. and Harry B. Helmsley Nanotechnology Research Fund.
Prof. Peer’s work was among the first to demonstrate systemic delivery of RNAi molecules using targeted nanocarriers to the immune system and he pioneered the use of RNA interference (RNAi) for in vivo validation of new drug targets within the immune system that has enormous implications in Cancer and inflammation.
Prof. Peer has more than 50 pending and granted patents. Some of them have been licensed to several pharmaceutical companies and one is currently under registration (as a new drug in inflammatory bowel disease). In addition, based on his work, four spin-off companies were generated Leuko Biosciences, Quiet Therapeutics, SEPL Pharma and ART Bioscience aiming to bring personalized nanomedicine into clinical practice.
Prof. Peer a Member of the Israel Young Academy of Sciences.
Prof. Mark A. Reed received his Ph.D. from Syracuse University. He holds the Harold Hodgkinson Chair of Engineering and Applied Science at Yale University. He is the author of more than 200 professional publications, 6 books, and has given over 25 plenary and over 370 invited talks, and holds 25 patents. He is the Editor in Chief of the journal Nanotechnology. His awards include the Kilby Young Innovator Award, the Fujitsu ISCS Quantum Device Award, and the IEEE Pioneer Award in Nanotechnology. He is a Fellow of the American Physical Society and the Institute of Electrical and Electronics Engineers.
Dr. Simberg received his Ph.D. in Biochemistry at the Hebrew University of Jerusalem, Israel in the laboratory of Professor Chezy Barenholz. His thesis was on biochemical mechanisms of transfection using cationic lipids in vitro and in vivo. After his Ph.D. he did a 2-year postdoctoral study on tumor targeting using peptides in the laboratory of Prof. Erkki Ruoslahti in the Burnham Institute, La Jolla, USA. Dr. Simberg joined the University of Colorado as a faculty member in 2013. Dr. Simberg is the corresponding author of over 40 peer review publications, review articles, perspectives and book chapters, and recipient of multiple grants totaling over $8M. His current research interests are focused on the use of iron oxide nanoparticles and red blood cells for drug delivery and imaging, and on basic mechanisms of complement activation by nanomedicines.
Dr. Amit Kumar Goyal is Professor & Head, Department of Pharmaceutics, at ISF College of Pharmacy, Moga, Punjab. Dr. Goyal has completed his M.Pharm. and Ph.D. from Department of Pharmaceutical Sciences, Dr. H. S. Gour University, Sagar (M.P.). During his Ph.D. work, he has received M.P. Young Scientist Awards, 2006 MPCST, Bhopal for his research contribution in the designing dried powder vaccines and worked as Senior Research Fellow (DBT, New Delhi) for his doctoral work. Dr. Goyal is the leading scientist in the field of cutting age platform technology (Nanotechnology) for site specific targeted delivery of drugs and bio-actives.
Jingwei Xie received his B.S. (1999) and M.S. (2002) from Nanjing University of Technology, China, and his Ph.D. from the National University of Singapore (2007). He worked as a postdoctoral fellow in the Xia group at Washington University in St. Louis (2007-2011) and then as a Senior Scientist at Marshall University (2011-2013). He is currently an Assistant Professor in the Department of Surgery-Transplant and Holland Regenerative Medicine Program at the University of Nebraska Medical Center. His research interests include biomaterials, drug delivery, nanomedicine, tissue engineering, and regenerative medicine.
Mahmoud Nasrollahzadeh was born in 1981 in Babol (Iran). He received his BSc (2003) in applied chemistry and MSc (2007) in organic chemistry. In 2012 he graduated his PhD in organic chemistry at the Bu-Ali Sina University, Iran and then he joined to chemistry department at the University of Qom as assistant professor. His research interests were the preparation of novel organic molecules, polymer supported metal compelexes and new organometallic catalysis for C-C and C-X coupling reactions. Now, his research interests are new processes and scale-up in organic chemistry, organometallic catalysis, phytochemistry, plant-mediated green synthesis of metal and metal oxides.
Barbara Klajnert-Maculewicz has completed her Ph.D in 2002 from the University of Lodz, Poland and postdoctoral studies from the McMaster University, Ontario, Canada. She is a professor at the University of Lodz, Poland and an external scientific member at Leibniz IPF in Dresden, Germany. She is a co-author of 2 books and 9 chapters in monographs. She has published more than 90 papers in reputed journals (h-index 23). In the years 2009-2012 she was the Management Committee Chair of COST Action TD0802 “Dendrimers in biomedical applications” that gathered 24 countries. She has been awarded L’Oréal-UNESCO Fellowship for Women in Science
Yilmaz Capan is Professor of Pharmaceutical Technology and Head of the Pharmaceutical Technology Department at Hacettepe University Faculty of Pharmacy, Ankara, Turkey. Professor Capan received his Ph.D. from the University of Lille II, France in 1978. He has been a Visiting Scientist at University of Lille II, Faculty of Pharmacy and at University Paris-Sud, Faculty of Pharmacy, Paris-France and was a Visiting Professor at Louis Pasteur University, Faculty of Pharmacy, Strasbourg-France and at University of Kentucky College of Pharmacy. He has thirty-five published refereed-journal articles, twenty published non-refereed journal articles and three published books. Professor Capan holds memberships in the American Association of Pharmaceutical Scientists, Association of Pharmaceutical Sciences of Ankara, Turkish Pharmacists' Association and Pharmacist's Chamber of Ankara.
Donald A. Tomalia is the CEO/Founder of NanoSynthons LLC and National Dendrimer & Nanotechnology Center; Adjunct Professor (Department of Chemistry) University of Pennsylvania, PA and Affiliate Prof. (Department of Physics) Virginia Commonwealth University, VA. He received his B.A. in Chemistry from the University of Michigan and Ph.D. in Physical–Organic Chemistry from Michigan State University while working at The Dow Chemical Company (1962-1990). He has founded three dendrimer-based nanotechnology companies; namely: NanoSynthons LLC (2010), Dendritic Nanotechnologies, Inc. (2001) and Dendritech, Inc. (1992). Other positions currently held by Tomalia include: Scientific Advisory Board CLINAM, European Foundation for Clinical Nanomedicine; Sr. Scientific Advisor to the European Union CosmoPHOS Nano Project (2012-present). Dr. Tomalia also serves as Faculty Member, Faculty 1000 Biology; Associate Editor, Journal of Nanoparticle Research (Springer); Editorial Advisory Board, Nanomedicine (Elsevier) and Current Bionanotechnology.
Dr. Mäder obtained his PhD in Pharmacy at the Humboldt-University Berlin. After his Postdoc time at Dartmouth Medical School (NH, USA) he completed his Habilitation in Berlin. Academic (Marburg, FU Berlin) and industrial (Roche, Basle) research positions followed. Since 2003 Dr. Mäder is Full Professor of Pharmaceutics at the Martin-Luther-University Halle-Wittenberg. He published around 170 papers, several book chapters and patents. Dr. Mäder received several awards, including the APV Research Award for Outstanding Achievements in Pharmaceutical Sciences, the Scheele-award of the German Pharmaceutical Society, the CRS-Capsugel award, the Young Investigator Award of the International EPR society, and the Phoenix Prize in Pharmaceutics.
Ken Howard is an Associate Professor and Group Leader at the Department of Molecular Biology at the Interdisciplinary Nanoscience Center (iNANO), Aarhus University, Denmark. His research and teaching activities are focused on delivery science, nanomedicine and RNA interference. Ken Howard received a PhD in Pharmaceutical Science from the University of Nottingham, UK, and has held postdoctoral positions at the CRC Institute for Cancer Studies, University of Birmingham, UK and the School of Pharmacy, University of London
Maria J. Blanco-Prieto received her Pharmacy Degree from the University of Santiago de Compostela (Spain), followed by a PhD in Pharmaceutical Sciences from the University of Paris-Sud (France). She completed a post-doctoral training at the Swiss Federal Institute of Technology (ETH), Zürich, (Switzerland) and then joined the University of Navarra where presently she is Full Professor of Pharmacy and Pharmaceutical Technology.
Her research lay in the field of biomaterials and advanced drug carrier systems including the design and the development of polymer and lipid based micro- and nanoscale carriers, their biological evaluation in in vitro cell cultures (toxicity, mechanism of action, intracellular drug release) and also their pharmacokinetic and dynamic impact in vivo (using relevant animal models of the diseases).
Prof. Blanco-Prieto is currently Editorial Advisory Board Member of this journal (Current Bionanotechnology, CBNT), published by Bentham Science Publishers.
Kenneth Wong, MD, PhD, FRCSEd, is a surgeon scientist at the University of Hong Kong. He received medical degree from University of Edinburgh and his Ph.D degree in immunology and post-doc training at Imperial College, University of London. He is currently Clinical Associate Professor in the Department of Surgery.
He is a specialist paediatric and neonatal surgeon with main clinical interests in neonatal surgery, advanced laparoscopic/ robotic surgery, gastrointestinal and thoracic surgery. He helped set up the paediatric robotic surgery programme and also introduced single port surgery, bariatric surgery and thoracoscopic surgery in children in Hong Kong. He has been co-project leader in “Laparoscopic Workshops for Paedaitric Surgeons in China” since 2007.
The major research areas of Dr. Wong include clinical applications of nanomedicine using various animal disease models, genome-wide association of childhood congenital disease, tissue repair and regeneration. Dr. Wong has published over 120 papers in peer-reviewed SCI journals and has contributed to 14 book chapters. He is currently on the editorial board of 8 clinical and scientific journals and has given over 100 invited lectures worldwide.
Dr. Geoffrey D. Bothun is an Associate Professor of Chemical Engineering at the University of Rhode Island, USA. Professor Bothun received BS degrees in Chemistry and Chemical Engineering from the University of Nevada, Reno in 1998 and MS/PhD degrees in Chemical Engineering from the University of Kentucky in 2004. He joined URI in 2006 as an Assistant Professor after completing a National Science Foundation Postdoctoral Fellowship, and was promoted to Associate Professor with tenure in 2011. In 2012 he was appointed as Director of the Rhode Island Consortium for Nanoscience and Nanotechnology, which is a statewide initiative supporting nanotechnology research and commercialization. Professor Bothun’s research is in the area of bionanotechnology with an emphasis on membrane biophysics, molecular self-assembly, and colloidal and interfacial phenomena
Dr. Peter Burkhard has obtained his PhD from the University of Basel, Switzerland. He is a professor at the University of Connecticut, Storrs, USA, in the field of nanobiotechnology. He is also co-Founder and CEO of Alpha-O Peptides AG, Riehen, Switzerland, a company dedicated to the development of nanoparticle vaccines. As a structural biologist he invented the so-called self-assembling protein nanoparticles (SAPN) as a platform for vaccine design.
Giuseppe Chirico is currently professor of Applied Physics at the Department of Physics, University of Milano Bicocca (Milano, Italy)
After a degree in Physics, he gained the doctorate in Biophysics in 1990. He has been postdoc at the European Molecular Biology Laboratory (EMBL, Grenoble Outstation, France), visiting Researcher at the German Cancer research center (DKFZ, Heidelberg, Germany) and visiting professor at the Laboratory for Fluorescence Dynamics (LFD, University of Illinois at Urbana-Champaign.
GC employs laser spectroscopy and non-linear excitation microscopy to investigate the structure and dynamics of cells and their interaction with nanoparticles. His main focus is currently the development of correlative methods for the image analysis and adaptive optics for in-vivo microscopy. He is co-author of more than 130 publications in international scientific journals.
Dr. Jianhong XU received his B.Sc. and Ph.D. at Tsinghua University in 2002 and 2007 respectively. He continued his research in Tsinghua University as a postdoctor after graduation. He finished the postdoctoral program in May 2009, and became a formal faculty of the Department of Chemical Engineering, Tsinghua University. He was promoted to associate professor in Dec. 2010. He had studied as a visiting scholar at Prof. David Weitz lab in Harvard University during 2012.7~2013.6. At present, his research areas are focusing on the multiphase microfluidics and functional materials synthesis. He has more than 100 peer-reviewed publications. He got the “Excellent Young Scientists Fund” from the National Natural Science Foundation of China (NSFC) in 2013.
Dr. Kim received his PhD degree from the Department of Materials Science and Engineering at Seoul National University, Korea, in 2001. Currently, Dr. Kim is a Professor of the School of Civil, Environmental, and Architectural Engineering at Korea University, Korea. His research encompasses two major areas: nanostructuring of functional materials using biotemplates and their applications to energy and environmental systems. He has published more than 200 scientific publications.
Dr. Lee obtained Ph.D. in Chemistry and Biochemistry, the University of Texas at Austin. Currently, Dr. Lee is Professor at Department of Bioengineering, University of California, Berkeley. He is also Faculty Scientist, Lawrence Berkeley National Laboratory. The Lee group uses chemical and biological approaches to create precisely defined nanomaterials, to investigate complex phenomena at their interfaces, and to develop novel, biomimetic, functional materials. Among numerous awards, Professor Lee is R&D 100 Award (2013 and 2015) and an NSF CAREER awardee. Dr. Lee’s on going research was chosen as one of 12 highlight researches chosen by the President Obama’s National Science Foundation Report for the US Congress entitled “Manufacturing Goes Viral” (2014) and chosen as one of top five Future Nanomanufacturings by Scientific American (2013).
Jianye Li obtained a Master of Science degree in physical chemistry from Shandong University in 1992 and a doctorate (Ph.D.) in physical chemistry from University of Science & Technology Beijing in 2001 respectively. From 2002 to 2007, he worked as a research associate in Department of Chemistry at Duke and Department of Materials Science & Engineering at Northwestern. From 2007, Jianye Li joined University of Science & Technology Beijing as a professor in the Department of Physical Chemistry. He has published over 70 scientific publications.
Jinghong Li is currently a Cheung Kong Professor at the Department of Chemistry at Tsinghua University, China. He received his PhD degree from Changchun Institute of Applied Chemistry, Chinese Academy of Sciences in 1996. He spent several years at the University of Illinois at Urbana-Champaign, University of California at Santa Barbara, Clemson University, and Evonyx Inc., New York. He joined the faculty of Tsinghua University in 2004. His current research interests include electroanalytical chemistry, bio-electrochemistry and sensors, nanoanlytical chemistry and single cell analysis, physical electrochemistry and interfacial electrochemistry, electrochemical materials science and nanoscopic electrochemistry. He has published over 300 papers in international, peer-reviewed journals and > 21,500 citations, giving him an h-index of 78. http://www.researcherid.com/rid/D-4283-2012
Dr. Eng. Podhorodecki obtained a doctorate (Ph.D.) in Physics from the Wroclaw University of Technology (WRUT), Wroclaw, Poland. Recently he is a Professor at WRUT where he is leading a group working on synthesis, functionalization, optical spectroscopy and optical imaging of inorganic nanostructures. His team is mainly working on semiconducting and lanthanides doped nanostructures for bio-medical as well optoelectronic applications. In 2012-2106 he was a member of the Council of National Centre for Research and Development in Poland. So far, ( <2016) he has published more than 90 scientific publications.
Dr. Pyayt is an Assistant Professor at Department of Chemical and Biomedical Engineering, University of South Florida. Dr. Pyayt earned her dual Ph.D. in Electrical Engineering and Nanotechnology from the University of Washington. Her inventions are Telescopic Pixel (a competitor to LCD) that Dr. Pyayt created in collaboration with Microsoft Research gained international media attention and was highlighted in high-profile journals, like Nature, and other top scientific venues. The original publication was translated into more than 30 languages worldwide. Novel optical interconnect between a photonic and multiple plasmonic waveguides enabling fabrication of new Biomedical nano-chips (published in Nature Nanotechnology).
Stefaan C. De Smedt is the Director of the Ghent Research Group on Nanomedicines (Belgium). He served as a dean of his faculty and is currently a member of the Board of Directors of Ghent University. He has been elected as member of the Belgian Royal Academy of Medicine. Dr. De Smedt serves as the Editor of the Journal of Controlled Release (for Europe- the Middle East & Africa). For his research, which is at the interface between drug delivery, biophysics & material sciences, he received the CRS Young Investigator Award 2006 and the APV Research Award 2010 for Outstanding Research Achievements in Pharmaceutical Sciences. He is a scientific founder of Memobead Technologies and a member of the Drug Delivery Advisory Panel of Santen.
Dr. Yoke Khin Yap earned his Ph.D. degree in Electrical Engineering from Osaka University, Japan. He is a professor of physics, and the director of applied physics program at Michigan Technological University (MTU). Dr. Yap was a Monbusho scholar for his Ph.D program, a Fellow of the Japan Society for the Promotion of Science (JSPS) during his postdoctoral tenure, and a recipient of the U.S. National Science Foundation CAREER Award. In 2015 Dr. Yap is honored as an Osaka University Global Alumni Fellow. Dr. Yap has published a series book and encyclopedia chapters in the area of nanoscale materials, organized a series of symposia in the Materials Research Society Meetings, and served as an advisory board member in conferences and journals.
Prof. Ying is currently Executive Director of the Institute of Bioengineering and Nanotechnology (IBN), Singapore. IBN is multidisciplinary institute founded by Prof. Ying in March 2003 to advance frontiers of engineering, science and medicine. IBN’s research is focused on nanomedicine, synthetic biosystems, biodevices and diagnostics, green chemistry and energy. Prof. Ying’s research is interdisciplinary in nature, with a theme in the synthesis of advanced nanostructured materials for biomaterial and catalytic applications. Prof. Ying has authored over 350 articles with more than 21,900 citations (h index: 70). She has presented over 440 invited lectures at international conferences, and 110 invited seminars.